5q- Syndrome

Search Trials
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Sep 7, 2018
First Changed:
Jan 10, 2011
Disease(s):
Acute Undifferentiated Leukemia
Intervention(s):
deferasiroxlaboratory biomarker analysisenzyme-linked immunosorbent assay
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
Status:
Completed
Last Changed:
Jul 24, 2018
First Changed:
Feb 12, 2013
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
vorinostattacrolimuscyclosporinemethotrexatelaboratory biomarker analysispharmacological study
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Status:
Active, not recruiting
Last Changed:
Feb 27, 2018
First Changed:
Mar 9, 2004
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatetotal-body irradiationnonmyeloablative allogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantationcyclosporinemycophenolate mofetillaboratory biomarker analysis
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Status:
Terminated
Last Changed:
Jun 18, 2019
First Changed:
Jul 9, 2010
Disease(s):
Iron Overload
Intervention(s):
deferasirox
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Status:
Withdrawn
Last Changed:
Jul 9, 2012
First Changed:
Mar 20, 2012
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
management of therapy complicationsmusculoskeletal complications management/prevention

Connect. Empower. Inspire.